Back to top
more

Amgen (AMGN)

(Delayed Data from NSDQ)

$333.83 USD

333.83
1,296,728

+2.82 (0.85%)

Updated Aug 30, 2024 03:59 PM ET

After-Market: $331.60 -2.23 (-0.67%) 5:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (83 out of 251)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Thousand Oaks, CA-based Amgen is one of the biggest biotech companies in the world, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health and nephrology markets. The company used advances in cellular and molecular biology to develop two of the biotech industry’s earliest and most successful drugs, Epogen (anemia) and Neupogen (white blood cell stimulant). Amgen successfully launched two next-generation products, Aranesp and Neulasta. Meanwhile, the acquisition of Immunex Corporation gave Amgen access to the multi-blockbuster drug, Enbrel. However, all these older drugs are facing declining sales due to biosimilar or branded competition, which is being somewhat offset by its newer blockbuster drugs like Prolia/Xgeva

Amgen (AMGN) Dips More Than Broader Markets: What You Should Know

Amgen (AMGN) closed at $262.03 in the latest trading session, marking a -0.89% move from the prior day.

Horizon (HZNP) Dazodalibep Meets Goal in Sjogren's Syndrome Study

Horizon Therapeutics (HZNP) announces that a phase II Sjogren's syndrome study of its candidate, dazodalibep, meets the primary endpoint for the second population.

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Smart Beta ETF report for IBB

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Amgen (AMGN) Gains But Lags Market: What You Should Know

Amgen (AMGN) closed at $271.73 in the latest trading session, marking a +0.3% move from the prior day.

Should You Invest in the iShares Biotechnology ETF (IBB)?

Sector ETF report for IBB

Amgen (AMGN) Dips More Than Broader Markets: What You Should Know

Amgen (AMGN) closed the most recent trading day at $270.12, moving -1.85% from the previous trading session.

Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know

Amgen (AMGN) closed at $264.39 in the latest trading session, marking a +1.05% move from the prior day.

Sweta Killa headshot

Dow Jones Beats S&P 500 in 2022: 5 Hot Stocks

The Dow Jones fared as the best of the indexes and five stocks -- Chevron (CVX), Merck (MRK), Travelers (TRV), Amgen (AMGN), and Caterpillar (CAT) -- gained in double-digits in 2022.

Amgen (AMGN) Gains But Lags Market: What You Should Know

Amgen (AMGN) closed at $263.16 in the latest trading session, marking a +0.67% move from the prior day.

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Investment Ideas feature highlights: Caterpillar, Chevron and Amgen

Caterpillar, Chevron and Amgen have been highlighted in this Investment Ideas article.

Derek Lewis headshot

3 Top Performing Blue-Chips of 2022

Many investors have flocked to blue-chip stocks in 2022 to shield themselves from volatility. Can the strength of these three stocks spill into 2023?

Amgen (AMGN) Stock Moves -0.2%: What You Should Know

Amgen (AMGN) closed the most recent trading day at $263.39, moving -0.2% from the previous trading session.

Mirati's (MRTX) Krazati Gets Breakthrough Therapy Tag for CRC

The FDA bestows a Breakthrough Therapy designation to Mirati's (MRTX) Krazati (adagrasib) for treating patients with advanced, KRAS-mutated colorectal cancer.

The Zacks Analyst Blog Highlights Broadcom, United Parcel Service, Amgen, America Movil and Manulife Financial

Broadcom, United Parcel Service, Amgen, America Movil and Manulife Financial are part of the Zacks top Analyst Blog.

Sheraz Mian headshot

Q4 Earnings Season Update and Analyst Reports for Broadcom, UPS & Amgen

Today's Research Daily features update on the Q4 earnings season and new research reports on Broadcom (AVGO), UPS (UPS), Amgen (AMGN) and 16 other stocks.

Amgen (AMGN) Stock Moves -0.64%: What You Should Know

In the latest trading session, Amgen (AMGN) closed at $265.70, marking a -0.64% move from the previous day.

Cytokinetics (CYTK) Up Despite Unfavorable FDA Committee Voting

Cytokinetics (CYTK) gets an unfavorable recommendation from CRDAC on omecamtiv mecarbil for the treatment of heart failure with reduced ejection fraction.

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

5 Stocks to Watch on Dividend Hikes Before 2022 Wraps Up

Investors may keep a tab on LW, NUE, PWRr, TTC, and AMGN which have lately hiked their dividend payments to reward investors.

Biotech Stock Roundup: HZNP Surges on AMGN Offer, TRDA Gains on VRTX Deal & More

Acquisitions news from HZNP and AMGN form the key highlights from the biotech sector during the past week.

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Amgen (AMGN) closed at $272.26, marking a -1.63% move from the previous day.

Andrew Rocco headshot

Trending Today: 5 Stocks in the News

So far this week, several stocks have had headline-driven catalysts. We will cover 5 stocks trending in the news.